HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren's syndrome.

AbstractOBJECTIVE:
To test the hypothesis that the formation of ectopic germinal center (GC)-like structures in Sjögren's syndrome (SS) is associated with the ectopic expression of the constitutive lymphoid tissue-homing chemokines B cell-attracting chemokine 1 (BCA-1; or, CXCL13) and stromal cell-derived factor 1 (SDF-1; or, CXCL12).
METHODS:
Immunohistochemical and immunofluorescence analysis was used to determine the expression of the constitutive chemokines BCA-1 (CXCL13) and SDF-1 (CXCL12) in salivary glands from 5 SS patients and 3 non-SS patients. In addition, the expression of their respective receptors (CXCR5 and CXCR4) was examined on infiltrating lymphocytes. Human tonsil was used as a positive control for secondary lymphoid tissue.
RESULTS:
BCA-1 (CXCL13) was expressed within lymphoid aggregates in SS, which shared many structural features with GCs in tonsil. BCA-1 (CXCL13) was completely absent in control biopsy samples from patients who did not have SS. High levels of BCA-1 (CXCL13) were also found on endothelial cells in salivary glands from SS patients. Diseased SS tissue was infiltrated by CXCR5-expressing B cells which organized into GC-like clusters. In complete contrast, SDF-1 (CXCL12), a constitutive chemokine involved in leukocyte retention within lymphoid tissue, was expressed by epithelial cells in both diseased and control samples. The chemokine receptor for SDF-1, CXCR4, was expressed on T cells that accumulated in a periductal distribution in diseased tissue.
CONCLUSION:
The ectopic expression of BCA-1 (CXCL13) on endothelial cells and within GC-like structures, together with the strong expression of SDF-1 (CXCL12) on ductal epithelial cells, is a unique feature of inflamed glands in SS. By creating a local microenvironment supportive of focal B cell aggregation and differentiation, with structural features that are remarkably similar to GCs, BCA-1 (CXCL13) and SDF-1 (CXCL12) may contribute to the excessive production of high-affinity, class-switched autoantibodies and to the high incidence of B cell lymphomas classically associated with SS.
AuthorsN Amft, S J Curnow, D Scheel-Toellner, A Devadas, J Oates, J Crocker, J Hamburger, J Ainsworth, J Mathews, M Salmon, S J Bowman, C D Buckley
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 44 Issue 11 Pg. 2633-41 (Nov 2001) ISSN: 0004-3591 [Print] United States
PMID11710719 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • CXCL12 protein, human
  • CXCL13 protein, human
  • CXCR5 protein, human
  • Chemokine CXCL12
  • Chemokine CXCL13
  • Chemokines, CXC
  • Receptors, CXCR4
  • Receptors, CXCR5
  • Receptors, Chemokine
  • Receptors, Cytokine
Topics
  • B-Lymphocytes (metabolism)
  • Chemokine CXCL12
  • Chemokine CXCL13
  • Chemokines, CXC (analysis, biosynthesis)
  • Endothelium, Lymphatic (metabolism, pathology)
  • Fluorescent Antibody Technique, Indirect
  • Germinal Center (metabolism, pathology)
  • Humans
  • Immunohistochemistry
  • Palatine Tonsil (metabolism, pathology)
  • Parotid Gland (metabolism, pathology)
  • Receptors, CXCR4 (biosynthesis)
  • Receptors, CXCR5
  • Receptors, Chemokine
  • Receptors, Cytokine (biosynthesis)
  • Salivary Glands, Minor (metabolism, pathology)
  • Sjogren's Syndrome (metabolism, pathology)
  • Tonsillitis (metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: